z-logo
open-access-imgOpen Access
Endothelial nitric oxide synthase (−786T>C) polymorphism and migraine susceptibility
Author(s) -
Dongyi Han,
Zhi Hao Wang,
Bin Dong,
HU Ya,
Hui Zhao
Publication year - 2018
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000012241
Subject(s) - medicine , migraine , genotype , enos , subgroup analysis , gastroenterology , allele , polymorphism (computer science) , meta analysis , endocrinology , nitric oxide synthase , nitric oxide , genetics , biology , gene
Background: The aim of this study was to evaluate the correlation between endothelial nitric oxide synthase (eNOS) polymorphism (−786T>C) and migraine susceptibility in a meta-analysis. Methods: A literature search was performed for case–control studies from inception to July 30, 2018 focusing on eNOS polymorphism (−786T>C) and risk of migraine. From 454 full-text articles, 6 were included in this study. Heterogeneity was assessed with the I 2 index and quality assessment was performed using the Newcastle–Ottawa scale. Results: CC genotype was not related to higher susceptibility of migraine compared with TT+ TC genotypes with significant difference (fixed effects model; OR = 1.27; 95% CI = 0.90–1.80; P =  .17; I 2  = 18%). However, subgroup analysis showed CC variant increase the risk for migraine compared with TT+ TC genotypes in Caucasian populations (fixed effects model; OR = 1.62; 95% CI = 1.03–2.56; P =  .04; I 2  = 18%), which could not be observed in non-Caucasian populations (fixed effects model; OR = 0.88; 95% CI = 0.51–1.53; P =  .66; I 2  = 0%). There was no significant difference for other genotypes and alleles between patients with migraine and healthy controls (all P >  .05). Conclusion: This meta-analysis indicated that CC variant increases the risk for migraine compared with TT + TC genotypes in Caucasian populations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here